Portal Biotechnologies
Latest round
- Seed
Last raised
- Dec 2024
Total raised
- $13M
Investors
- 7
About Portal Biotechnologies
Based in Massachusetts, US, and founded in 2023 by CEO Armon Sharei, Portal Biotechnologies specialises in developing advanced platforms that facilitate the efficient delivery of various cargoes into a diverse range of cell types, including but not limited to T cells, B cells, NK cells, and iPSCs. In December 2024, Portal Biotechnologies, Inc. Portal's flagship product, The Gateway, offers performance in boosting cell function compatibility across a diverse range of cell types and cargoes, including mRNA, siRNA, proteins, CRISPR RNPs, small molecules, and more. Their proprietary membrane is optimised for delivery, cell viability, and flexible buffer compatibility. Additionally, the product is future-proof, with a subscription model that includes free hardware upgrades to future models. Portal's partner network includes various entities in the life sciences field, such as biotech companies, pharmaceutical companies, academic institutions, and cell therapy manufacturers.
Who invested in Portal Biotechnologies
7 investors across 2 rounds
See all investors in Portal Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Portal Biotechnologies
Who invested in Portal Biotechnologies?
Portal Biotechnologies has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Portal Biotechnologies raised?
Portal Biotechnologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Portal Biotechnologies last raise money?
Portal Biotechnologies's most recent round on record is a Seed, in Dec 2024.
What does Portal Biotechnologies do?
Based in Massachusetts, US, and founded in 2023 by CEO Armon Sharei, Portal Biotechnologies specialises in developing advanced platforms that facilitate the efficient delivery of various cargoes into a diverse range of cell types, including but not limited to T cells, B cells, NK cells, and iPSCs.
Where is Portal Biotechnologies headquartered?
Portal Biotechnologies is headquartered in Watertown, US.
Which VCs invest in companies like Portal Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Portal Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Portal Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.